MyFinsight
Home
About
Contact
cnta: the income statement
Download
Download image
Unrealized (loss) gain on
available for sale...
$318K
Foreign currency
translation adjustment
$691K
(267.72%↑ Y/Y)
Total comprehensive
loss
-$53,882K
(-28.09%↓ Y/Y)
Other comprehensive
(loss) income
$1,009K
(101.80%↑ Y/Y)
Net loss
-$54,891K
(-28.96%↓ Y/Y)
Income tax expense
$166K
(-72.70%↓ Y/Y)
Loss before income
taxes
-$54,725K
(-30.43%↓ Y/Y)
Interest and investment
income
$3,765K
(12.72%↑ Y/Y)
Other non-operating
income (expense), net
-$1,810K
(-149.40%↓ Y/Y)
Interest expense
$2,890K
(13.02%↑ Y/Y)
Loss from operations
-$53,790K
(-15.91%↓ Y/Y)
General and
administrative
$12,227K
(-2.20%↓ Y/Y)
Research and development
$41,563K
(22.59%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc (CNTA)